Nonoperative Management of Cervical Radiculopathy
Non-Small Cell Lung Cancer Treatment (PDQ®)–Patient Version - National Cancer Institute
Background: The result would be disastrous if the superior pulmonary sulcus tumor Pancoast tumor was misdiagnosed as degenerative cervical spine diseases. The aim of this study was to investigate the differential diagnosis methods of cervical radiculopathy and superior pulmonary sulcus tumor. Methods: Clinical manifestations, physical, and radiological findings of 10 patients, whose main complaints were radiating shoulder and arm pain and later were diagnosed with superior pulmonary sulcus tumor, were reviewed and compared with those of cervical radiculopathy. Results: Superior pulmonary sulcus tumor patients have shorter mean history and fewer complaints of neck pain or limitation of neck movement. Physical examination showed almost normal cervical spine range of motion. Spurling's neck compression test was negative in all patients.
An Overview of Pancoast Tumors of the Lungs
The topic of red flags intrigues me. Some practitioners would say that the diagnostic utility of red flags is not very strong, and they are not entirely wrong in making this claim based on our currently available evidence. Nonetheless, we need something to use to help guide our clinical decision making. From my experience using special questions to try identify red flags has been very useful, especially when I know what I am looking for. When you ask your special questions you really need to have an idea of what competing conditions have made their way onto your hypothesis list.
Thanks to breakthroughs in treatment, the Pancoast tumor survival rate has been steadily improving over the last several years. What was once considered an incurable cancer is now viewed as a treatable condition — especially when it is diagnosed in the earlier stages of its progression. For patients with early-stage, surgically-treatable cancer, the five-year survival rate is generally considered to be between 30 and 50 percent, although rates as high as 90 percent have been more reported in patient groups with very favorable characteristics. The survival rate is often highest among Pancoast tumor patients who:.